A simple risk scoring system for predicting acute exacerbation of interstitial pneumonia after pulmonary resection in lung cancer patients

[1]  Kenji Suzuki,et al.  Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer. , 2014, The Journal of thoracic and cardiovascular surgery.

[2]  A. Wells,et al.  Acute Exacerbations of Idiopathic Pulmonary Fibrosis , 2013, Respiration.

[3]  T. Higami,et al.  Surgical treatment for primary lung cancer combined with idiopathic pulmonary fibrosis , 2013, General Thoracic and Cardiovascular Surgery.

[4]  Luca Richeldi,et al.  Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. , 2011, The New England journal of medicine.

[5]  Yukiko Nakamura,et al.  The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  Takeshi Johkoh,et al.  American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management , 2011 .

[7]  H. Collard,et al.  Clinical course and prediction of survival in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[8]  G. Raghu,et al.  Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[9]  D. Lynch,et al.  BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis. , 2011, American journal of respiratory and critical care medicine.

[10]  I. Yoshino,et al.  Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography , 2011, Surgery Today.

[11]  E. Miyaoka,et al.  Japanese Lung Cancer Registry Study: First Prospective Enrollment of a Large Number of Surgical and Nonsurgical Cases in 2002 , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  Jong-Min Song,et al.  Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome , 2010, European Respiratory Journal.

[13]  Y. Ohno,et al.  Predictive factors for postoperative acute exacerbation of interstitial pneumonia combined with lung cancer , 2010, General thoracic and cardiovascular surgery.

[14]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[15]  M. Raza.  BUILD-1: A Randomized Placebo-Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis , 2009 .

[16]  A. Yoshimura,et al.  Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. , 2009, Internal medicine.

[17]  M. Nishimura,et al.  Prognostic value of circulating KL‐6 in idiopathic pulmonary fibrosis , 2006, Respirology.

[18]  S. Kudoh,et al.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. , 2005, American journal of respiratory and critical care medicine.

[19]  T. D’amico,et al.  Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection , 2004, Seminars in cardiothoracic and vascular anesthesia.

[20]  N. Kohno.  [Sialylated carbohydrate antigen KL-6]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[21]  G. Raghu,et al.  The epidemiology of interstitial lung disease and its association with lung cancer , 2004, British Journal of Cancer.

[22]  A. Nicholson,et al.  Pulmonary fibrosis and lung cancer: risk and benefit analysis of pulmonary resection. , 2003, The Journal of thoracic and cardiovascular surgery.

[23]  D. Schroeder,et al.  High short-term mortality following lung biopsy for usual interstitial pneumonia. , 2001, The European respiratory journal.

[24]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[25]  N. Kohno,et al.  New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. , 1989, Chest.

[26]  A. Kondoo.  Acute Exacerbation in Idiopathic Interstitial Pneumonia , 1989 .